Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Specificity of time- and dose-dependent morphological endpoints in the fish embryo acute toxicity (FET) test for substances with diverse modes of action: the search for a "fingerprint". | Environ Sci Pollut Res Int | 2022 | 34643865 | PubTator, text mining | PubMed |
| Preventing excess replication origin activation to ensure genome stability. | Trends Genet | 2022 | 34625299 | PubTator, text mining | PubMed |
| Selective Inhibitors of Histone Deacetylase 10 (HDAC-10). | Curr Med Chem | 2022 | 34468295 | PubTator, text mining | PubMed |
| Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma. | Acta Pharmacol Sin | 2022 | 34341512 | PubTator, text mining | PubMed |
| Advances in optimizing enzyme electrostatic preorganization. | Curr Opin Struct Biol | 2022 | 34280872 | PubTator, text mining | PubMed |
| Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective. | Curr Neuropharmacol | 2022 | 34151764 | PubTator, text mining | PubMed |
| Cinnamaldehyde induces autophagy-mediated cell death through ER stress and epigenetic modification in gastric cancer cells. | Acta Pharmacol Sin | 2022 | 33980998 | PubTator, text mining | PubMed |
| Targeting the acetylation signaling pathway in cancer therapy. | Semin Cancer Biol | 2022 | 33705871 | PubTator, text mining | PubMed |
| Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals. | Free Radic Biol Med | 2022 | 33359432 | PubTator, text mining | PubMed |
| Epigenetic-based cancer therapeutics: new potential HDAC8 inhibitors. | J Biomol Struct Dyn | 2022 | 32886033 | PubTator, text mining | PubMed |
| Electric Fields in Catalysis: From Enzymes to Molecular Catalysts. | ACS Catal | 2021 | 36245474 | PubTator, text mining | PubMed |
| Evaluation of histone deacetylase inhibitor substituted zinc and indium phthalocyanines for chemo- and photodynamic therapy. | RSC Adv | 2021 | 35494743 | PubTator, text mining | PubMed |
| Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer. | RSC Adv | 2021 | 35478899 | PubTator, text mining | PubMed |
| Recent progress in chemical approaches for the development of novel neuraminidase inhibitors. | RSC Adv | 2021 | 35424082 | PubTator, text mining | PubMed |
| Retraction: Overexpression of HDAC8 and down-regulation of CDKN2A is associated with worse prognosis of esophageal squamous cell carcinoma. | Transl Cancer Res | 2021 | 35129551 | PubTator, text mining | PubMed |
| Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation. | Front Cardiovasc Med | 2021 | 35127848 | PubTator, text mining | PubMed |
| PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma. | Transl Cancer Res | 2021 | 35116547 | PubTator, text mining | PubMed |
| Integrating RNA-Seq With GWAS Reveals a Novel SNP in Immune-Related HLA-DQB1 Gene Associated With Occupational Pulmonary Fibrosis Risk: A Multi-Stage Study. | Front Immunol | 2021 | 35111164 | PubTator, text mining | PubMed |
| Can the Synergic Contribution of Multigenic Variants Explain the Clinical and Cellular Phenotypes of a Neurodevelopmental Disorder? | Genes (Basel) | 2021 | 35052418 | PubTator, text mining | PubMed |
| The Regulation of Growth in Developing, Homeostatic, and Regenerating Tetrapod Limbs: A Minireview. | Front Cell Dev Biol | 2021 | 35047496 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=44